about
Lipoxins and aspirin-triggered lipoxins in resolution of inflammationResolvin D1 binds human phagocytes with evidence for proresolving receptorsPro-Resolving Lipid Mediators (SPMs) and Their Actions in Regulating miRNA in Novel Resolution Circuits in InflammationResolvin E1 receptor activation signals phosphorylation and phagocytosis.Pro-resolving actions and stereoselective biosynthesis of 18S E-series resolvins in human leukocytes and murine inflammationMicroRNAs in resolution of acute inflammation: identification of novel resolvin D1-miRNA circuits.Resolvin D1 receptor stereoselectivity and regulation of inflammation and proresolving microRNAs.Requirement for the histone deacetylase Hdac3 for the inflammatory gene expression program in macrophages.Human Periodontal Stem Cells Release Specialized Proresolving Mediators and Carry Immunomodulatory and Prohealing Properties Regulated by LipoxinsResolvin D1 and its GPCRs in resolution circuits of inflammation.Transcriptional regulation of the human FPR2/ALX gene: evidence of a heritable genetic variant that impairs promoter activity.Cystic fibrosis transmembrane conductance regulator (CFTR) expression in human platelets: impact on mediators and mechanisms of the inflammatory response.MicroRNA-181b regulates ALX/FPR2 receptor expression and proresolution signaling in human macrophages.microRNA-181b is increased in cystic fibrosis cells and impairs lipoxin A4 receptor-dependent mechanisms of inflammation resolution and antimicrobial defense.Targeting caveolin-1 deficiency in bone marrow derived cells: a new therapeutic window for fibrotic diseases?Anti-inflammatory and pro-resolving properties of benzo-lipoxin A(4) analogs.The contribution of cyclooxygenase-1 and -2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapy.Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin "resistance".Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients.Immunoresolving actions of oral resolvin D1 include selective regulation of the transcription machinery in resolution-phase mouse macrophages.Lipoxin receptors.Resolution of sickle cell disease associated inflammation and tissue damage with 17R-Resolvin D1Homocysteine Modulates the CD40/CD40L System
P50
Q28260831-19E169BC-C42B-4790-91AD-801257BEBD33Q28270638-72BD43A7-4F7B-4E01-BB8F-1B72EA2A1585Q28716294-69856347-1B74-4648-9F71-A8C5AC29A410Q30493174-328FFCAC-1511-42B5-9186-80751A5B4F2FQ34157528-20820A4E-94E9-4E27-B79C-9610A9DACC76Q34502699-615ECC56-13CD-4FFF-B189-0FF7FA97BCB1Q35951840-839054FF-DC3B-45E2-A0F3-5565BDE8DA2BQ36342694-15D3C1DB-C647-4FEE-986A-93A56FEA0D4BQ36440765-81CD49DA-13C0-4906-A927-7413FBEF62E0Q38090253-FA1B2A4A-2B73-4951-9546-508B192871CEQ39434873-A0427C1D-0566-4021-B6DE-668E25BA0E7FQ39695780-34F25B7D-62CC-4638-9B8B-2C32FB6814A6Q41692945-85BE17FD-19A5-47F5-A5AB-116DBED24C20Q42677379-B2A9879E-F829-411A-983A-023389C0730DQ42833003-25B5763C-8083-437F-B4E4-66A01A59491DQ42942697-9222996C-59CB-4C14-A40D-2FC36AFA950EQ43249093-22CBA772-B395-433E-99AF-6033D39F9AA9Q46114498-C0F5E3F4-3096-4E9C-BDC0-88FA73373A66Q46549390-5EC7E5C4-3A99-470A-BEFB-365D119FD337Q48081194-1A194947-56F4-45A6-A624-014014C683A3Q55097258-C032628D-793E-4EF2-A543-4E95C3C92BDEQ58592833-ED1A9831-0211-4256-B2E4-FF68DC759985Q58882401-EB83C993-8C78-49D6-9F59-CE13072129DA
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-1409-5261
@en
name
Antonio Recchiuti
@ast
Antonio Recchiuti
@en
Antonio Recchiuti
@es
Antonio Recchiuti
@nl
type
label
Antonio Recchiuti
@ast
Antonio Recchiuti
@en
Antonio Recchiuti
@es
Antonio Recchiuti
@nl
prefLabel
Antonio Recchiuti
@ast
Antonio Recchiuti
@en
Antonio Recchiuti
@es
Antonio Recchiuti
@nl
P1053
K-7670-2016
P106
P1153
16402976200
P21
P31
P3829
P496
0000-0002-1409-5261